AZD 5718)

AZD 5718) Suppliers list
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com

AZD 5718) manufacturers

  • Atuliflapon
  • Atuliflapon pictures
  • $44.00
  • 2026-07-27
  • CAS:2041075-86-7
  • Purity: 99.28%
  • Supply Ability: 10g
AZD 5718) Basic information
Product Name:AZD 5718)
Synonyms:Cyclohexanecarboxamide, 2-[4-(5-methyl-1H-pyrazol-3-yl)benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)-;Inhibitor,inhibit,FLAP,AZD-5718,AZD 5718,artery,Atuliflapon,disease,Coronary,5-LO activating protein;(1R,2R)-2-[4-(5-methyl-1H-pyrazol-3-yl)benzoyl]-N-{4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-3-yl}cyclohexane-1-carboxamide;Atuliflapon (AZD5718);Atuliflapon, 10 mM in DMSO;(1R,2R)-2-(4-(5-Methyl-1H-pyrazol-3-yl)benzoyl)-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexane-1-carboxamide;Atuliflapon;Unii-NV6352Y6TV
CAS:2041075-86-7
MF:C24H26N6O3
MW:446.5
EINECS:
Product Categories:
Mol File:2041075-86-7.mol
AZD 5718) Structure
AZD 5718) Chemical Properties
Boiling point 851.1±65.0 °C(Predicted)
density 1.48±0.1 g/cm3(Predicted)
solubility DMSO : 125 mg/mL (279.96 mM; Need ultrasonic)
form Solid
pka13.12±0.10(Predicted)
color White to off-white
Safety Information
MSDS Information
AZD 5718) Usage And Synthesis
UsesAtuliflapon (AZD5718) is an orally active inhibitor of FLAP (5Lipoxygenase activating protein), with an IC50 of 2 nM. Atuliflapon is used in the study for coronary artery disease[1].
in vivo

Atuliflapon exhibits t1/2 of 0.45 h and 2.1 h in rat and dog by iv injection, respectively[1].
Atuliflapon shows no inhibition of 5-LO pathway activity in rodent blood[1].

References[1] Daniel Pettersen, et al. Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease. J Med Chem. 2019 May 9;62(9):4312-4324. DOI:10.1021/acs.jmedchem.8b02004
AZD 5718) Preparation Products And Raw materials
Tag:AZD 5718)(2041075-86-7) Related Product Information
AZD 5718) Cyclohexanecarboxamide, 2-[4-[3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- Immunology/Inflammation Compound Library Clinical Compound Library Anti-Cardiovascular disease Compound Library